# AMAG Pharmaceuticals: Pharmaceuticals, Waltham, United States

> AMAG Pharmaceuticals: AMAG Pharmaceuticals is a biopharmaceutical company that provides solutions for patients with complex, underserved conditions.

Source: https://millionrounds.com/startup/amag-pharmaceuticals (Millionrounds; every figure on the page links to its filing or article)

United States · [Pharmaceuticals startup](https://millionrounds.com/companies)

# AMAG Pharmaceuticals

AMAG Pharmaceuticals is a biopharmaceutical company that provides solutions for patients with complex, underserved conditions.

Funding reported Last round: Post ipo debt

Pharmaceuticals Waltham, United States

Company summary

- **Founded:** 1981 45 years old
- **Team:** 251 201 to 1,000 people
- **Funding reported:** $475M in dollars
- **Last round:** Post ipo debt May 2017

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for AMAG Pharmaceuticals has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say AMAG Pharmaceuticals raised

Funding, as reported

Reported in all **$475M** in dollars

Rounds **2**

Last round **Post ipo debt**

Last round date **May 2017**

## Founders and team

From AMAG Pharmaceuticals's own website: 1 founder, 11 on the team.

**Rolf Hoffman** CEO and Founder NavBio AG

- **Michael Porter** Chief Executive Officer
- **Emanuele Pizzo** Vice President, Finance, EU and International
- **Janine List** Vice President, Head of Business Planning and Analysis
- **Christine Poulin** President, North America & General Manager of Canada
- **Albert Dahouk** Chief Information Officer
- **Ozgur Kilic** Chief Financial Officer
- **Raghav Chari** Chief Innovation Officer
- **Fabio Fazio** EVP, Global Head of Quality
- **Andrew Teehan** Interim General Counsel
- **Claude Noesen** Independent Non-Executive Fund Director
- **Rajiv de Silva** Chairman

Advisers *Ildiko Mehes*

## On a portfolio page

Investors who name them

- [Athyrium Capital Management](https://millionrounds.com/fund/athyrium-capital-management-lp)

Each firm lists AMAG Pharmaceuticals on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## Pharmaceuticals in United States

Startups like it

- [**PL Developments** Westbury · founded 1988](https://millionrounds.com/startup/pl-developments)
- [**Remedi SeniorCare** Baltimore · founded 1954](https://millionrounds.com/startup/remedi-seniorcare)
- [**Spectrum Pharmaceuticals** Lake Forest · founded 1987](https://millionrounds.com/startup/spectrum-pharmaceuticals)
- [**moksha8 Pharmaceuticals** Berwyn · founded 2007](https://millionrounds.com/startup/moksha8-pharmaceuticals)
- [**Neurelis** San Diego · founded 2007](https://millionrounds.com/startup/neurelis)
- [**Amplyx Pharmaceuticals** San Diego · founded 2006](https://millionrounds.com/startup/amplyx-pharmaceuticals)
- [**Zosano Pharma** Fremont · founded 2006](https://millionrounds.com/startup/zosano-pharma)
- [**Alexza Pharmaceuticals** Fremont · founded 2001](https://millionrounds.com/startup/alexza-pharmaceuticals)

## Is this your company?

Add your raise, your deck and your story, and put AMAG Pharmaceuticals in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)